Boulder Diagnostics Inc. provides new diagnostic solutions to undeserved or underperforming disease diagnostics areas. It currently markets novel specific antibody reagents for the diagnosis of parasite infections.
In vitro diagnostics company also introduces SpiroFind® Vet for active Lyme Disease detection in dogs and horses BOULDER, Colo. and MELLRICHSTADT, Germany, Oct. 18, 2013 /PRNewswire/ — Boulder Diagnostics announces the European Market Launch of its CE marked GoutiFind™ in vitro diagnostic test for the detection of active Gout disease from whole blood. The GoutiFind™ test […]
BOULDER, Colo. and MELLRICHSTADT, Germany, Nov. 9, 2012 /PRNewswire/ — Boulder Diagnostics Inc. announced today the European market launch of the CE marked SpiroFind in vitro diagnostic test for the detection of active Lyme Borreliosis. The SpiroFind test is offered as a diagnostic service by the company's clinical diagnostic service laboratory in Mellrichstadt, Germany. The novel […]
BOULDER, Colo. and PORTLAND, Ore., Jan. 20, 2012 — Boulder Diagnostics Inc. and Portland State University (PSU) announced today the entry into a license and collaboration agreement to develop rapid diagnostic tests for homocysteine and related compounds based on a highly specific dye technology developed at PSU. Under the agreement Boulder will finance further research […]
